Observation of using GLP-1 receptor agonist for wellness of brain activity in type 2 diabetes patients with mild cognitive impairment
- Conditions
- Type 2 diabetes mild cognitive impairment
- Registration Number
- JPRN-UMIN000030840
- Lead Sponsor
- Ogawa Red Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Not provided
1)Type 1 diabetes or suspicion of Type 1 diabetes 2)Dosing of insulin injection 3)Suspicion of dementia (MoCA-J score is 17 and below and/or MMSE score is 23 and below) 4)Dosing of weekly DPP-4 inhibitor 5)Severe ketosis, diabetic coma or precoma 6)Clinical history of pancreatitis 7)Severe infectious disease, pre/post-surgery or serious trauma 8)Severe hepatic dysfunction 9)Pituitary or adrenal gland dysfunction 10)Status of dystrophy/starvation, irregular meal intake, dietary intake deficiency or hyposthenia 11)Excessive alcohol intake 12)Clinical history of allergy or hypersensitivity to GLP-1 receptor agonists 13)Pregnant/ possible pregnant, breastfeeding 14)Psychiatric disorder 15)Inappropriate patients for study participation judged by principal or clinical investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method